Balanced Pharma Inc

New Filing

CIK: 0001838860·Pharmaceuticals·DELAWARE·Filed: Jan 7, 2021

Total Offering

$656,250

Amount Sold

$481,125

Investors

8

First Sale

Dec 16, 2020

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2020
Non-Accredited Investors: No

Related Persons

Name	Role
JOHN SCOTT KEADLE	Related Person
JOHN SELIG	Related Person

Company

Balanced Pharma Inc

18204 MAINSAIL POINTE

CORNELIUS, NC, 28031

(704) 650-0249

SEC Filing

0001838860-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.